Skip to main content
. Author manuscript; available in PMC: 2018 Dec 20.
Published in final edited form as: FEBS Lett. 2014 May 21;588(14):2277–2281. doi: 10.1016/j.febslet.2014.05.012

Fig. 1.

Fig. 1.

Effect of LXR ligand on hepatic triglyceride content in Pparγ∆H mice. (A) T0901317-treated ob/ob-PparγWT or ob/ob-Pparγ∆H livers. (B) Liver weight and (C) hepatic triglyceride (TG) in mice belonging to each genotype. The number of mice belonging to each genotype was as follows. Control group (untreated): OB/OB-PparγWT, n = 5; ob/ob-PparγWT, n = 9; OB/OB-Pparγ∆H, n = 9; and ob/ob-Pparγ∆H, n = 6. T0901317-treated group: OB/OB-PparγWT, n = 6; ob/ob-PparγWT, n = 8; OB/OB-Pparγ∆H, n = 8; and ob/ob-Pparγ∆H, n = 6. Values are the mean ± SE. *p < 0.01, **p < 0.001 versus the untreated control.